Non-surgical Peridontal Treatment on Cardiovascular Risk Markers
Cardiovascular Risk Markers, Chronic Periodontitis
About this trial
This is an interventional treatment trial for Cardiovascular Risk Markers focused on measuring asymmetric dimethylarginine, endothelial nitric oxide synthase, homocysteine, monocyte chemoattractant protein-1
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of severe chronic periodontitis
Clinical diagnosis of periodontal health
Exclusion Criteria:
Systemic diseases such as diabetes, cardiovascular disease
Periodontal treatment within the previous year
Drugs such as systemic steroids, non-steroidal anti-inflammatory drugs, immunosuppressants, hormone drugs, contraceptives, anticoagulants, cholesterol regulating drugs, systemic antibiotics, antioxidants within the previous 3 months
Pregnant or lactating
Consumed alcohol
Smoker
Sites / Locations
Arms of the Study
Arm 1
Other
Non-surgical peridontal treatment
Patients with chronic periodontitis received non-surgical periodontal treatment, including scaling and root planing and polishing within 14 days under local anesthesia with manual and ultrasonic devices and standardized oral hygiene instructions including methods of tooth-brushing and interdental cleaning were also given to each one. A professional supragingival plaque control was applied on a regular basis every month.